DocuSign (DOCU) 10-Q 7 Jun 24 2025 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Apr. 30, 2024	May 31, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2024
Document Transition Report	false
Entity File Number	001-38465
Entity Registrant Name	DOCUSIGN, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	91-2183967
Entity Address, Address Line One	221 Main St.
Entity Address, Address Line Two	Suite 1550
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94105
City Area Code	415
Local Phone Number	489-4940
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	DOCU
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		204,716,354
Entity Central Index Key	0001261333
Current Fiscal Year End Date	--01-31
Amendment Flag	false
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q1

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Current assets
Cash and cash equivalents	$ 817,388	$ 797,060
Investments—current	269,400	248,402
Accounts receivable, net of allowance for doubtful accounts of $5,890 and $5,499 as of April 30, 2024 and January 31, 2024	306,152	439,299
Contract assets—current	12,319	15,922
Prepaid expenses and other current assets	84,540	66,984
Total current assets	1,489,799	1,567,667
Investments—noncurrent	139,108	121,977
Property and equipment, net	255,736	245,173
Operating lease right-of-use assets	119,997	123,188
Goodwill	352,450	353,138
Intangible assets, net	46,206	50,905
Deferred contract acquisition costs—noncurrent	415,739	409,627
Other assets—noncurrent	107,654	99,615
Total assets	2,926,689	2,971,290
Current liabilities
Accounts payable	17,700	19,029
Accrued expenses and other current liabilities	99,177	104,037
Accrued compensation	153,932	195,266
Contract liabilities—current	1,313,227	1,320,059
Operating lease liabilities—current	20,925	22,230
Total current liabilities	1,604,961	1,660,621
Contract liabilities—noncurrent	23,840	21,980
Operating lease liabilities—noncurrent	117,444	120,823
Deferred tax liability—noncurrent	18,037	16,795
Other liabilities—noncurrent	25,407	21,332
Total liabilities	1,789,689	1,841,551
Commitments and contingencies (Note 7)
Stockholders’ equity
Preferred stock, $0.0001 par value; 10,000 shares authorized, 0 shares issued and outstanding as of April 30, 2024 and January 31, 2024	0	0
Common stock, $0.0001 par value; 500,000 shares authorized, 204,701 shares outstanding as of April 30, 2024; 500,000 shares authorized, 205,326 shares outstanding as of January 31, 2024	20	21
Treasury stock, at cost: 26 shares as of April 30, 2024; 18 shares as of January 31, 2024	(2,670)	(2,164)
Additional paid-in capital	2,950,081	2,821,461
Accumulated other comprehensive loss	(24,910)	(19,360)
Accumulated deficit	(1,785,521)	(1,670,219)
Total stockholders’ equity	1,137,000	1,129,739
Total liabilities and equity	$ 2,926,689	$ 2,971,290

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Statement of Financial Position [Abstract]
Accounts receivable, allowance for credit loss	$ 5,890	$ 5,499
Preferred stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares outstanding (in shares)	204,701,000	205,326,000
Treasury stock, shares (in shares)	26,000	18,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Revenue:
Total revenue	$ 709,640	$ 661,388
Cost of revenue:
Total cost of revenue	149,446	136,487
Gross profit	560,194	524,901
Operating expenses:
Sales and marketing	281,644	280,605
Research and development	134,320	115,364
General and administrative	92,478	104,811
Restructuring and other related charges	29,124	28,772
Total operating expenses	537,566	529,552
Income (loss) from operations	22,628	(4,651)
Interest expense	(144)	(1,966)
Interest income and other income, net	14,109	12,245
Income before provision for income taxes	36,593	5,628
Provision for income taxes	2,833	5,089
Net income	$ 33,760	$ 539
Net income per share attributable to common stockholders:
Basic (in usd per share)	$ 0.16	$ 0
Diluted (in usd per share)	$ 0.16	$ 0
Weighted-average shares used in computing net income per share:
Basic (in shares)	205,870	202,631
Diluted (in shares)	209,896	208,071
Comprehensive income:
Foreign currency translation gain (loss), net of tax	$ (4,301)	$ 431
Unrealized gains (losses) on investments, net of tax	(1,249)	648
Other comprehensive income (loss)	(5,550)	1,079
Comprehensive income	28,210	1,618
Stock-based compensation expense included in costs and expenses:
Stock-based compensation expense	142,504	144,706
Sales and marketing
Stock-based compensation expense included in costs and expenses:
Stock-based compensation expense	46,271	45,326
Research and development
Stock-based compensation expense included in costs and expenses:
Stock-based compensation expense	44,202	35,997
General and administrative
Stock-based compensation expense included in costs and expenses:
Stock-based compensation expense	28,520	40,342
Restructuring and other related charges
Stock-based compensation expense included in costs and expenses:
Stock-based compensation expense	4,628	4,954
Subscription
Revenue:
Total revenue	691,483	639,307
Cost of revenue:
Total cost of revenue	126,602	108,942
Subscription | Cost of revenue
Stock-based compensation expense included in costs and expenses:
Stock-based compensation expense	14,181	11,357
Professional services and other
Revenue:
Total revenue	18,157	22,081
Cost of revenue:
Total cost of revenue	22,844	27,545
Professional services and other | Cost of revenue
Stock-based compensation expense included in costs and expenses:
Stock-based compensation expense	$ 4,702	$ 6,730

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2023		201,904
Beginning balance at Jan. 31, 2023	$ 617,287	$ 20	$ 2,240,732	$ (1,785)	$ (22,996)	$ (1,598,684)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		15
Exercise of stock options	127		127
Settlement of restricted stock units and employee stock purchase plan (in shares)		1,144
Tax withholding on net share settlement of restricted stock units and employee stock purchase plan (in shares)		(415)
Tax withholding on net share settlement of restricted stock units and employee stock purchase plan	(23,076)		(22,834)	(242)
Employee stock purchase plan (in shares)		420
Employee stock purchase plan	$ 18,390		18,390
Repurchases of common stock (in shares)	(700)	(709)
Repurchases of common stock	$ (40,472)					(40,472)
Settlement of capped calls, net of related costs	23,688		23,688
Employee stock-based compensation	151,930		151,930
Net income	539					539
Other comprehensive loss, net	1,079				1,079
Ending balance (in shares) at Apr. 30, 2023		202,359
Ending balance at Apr. 30, 2023	$ 749,492	$ 20	2,412,033	(2,027)	(21,917)	(1,638,617)
Beginning balance (in shares) at Jan. 31, 2024	205,326	205,326
Beginning balance at Jan. 31, 2024	$ 1,129,739	$ 21	2,821,461	(2,164)	(19,360)	(1,670,219)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	56	55
Exercise of stock options	$ 634		634
Settlement of restricted stock units and employee stock purchase plan (in shares)		2,088
Tax withholding on net share settlement of restricted stock units and employee stock purchase plan (in shares)		(796)
Tax withholding on net share settlement of restricted stock units and employee stock purchase plan	(45,351)		(44,845)	(506)
Employee stock purchase plan (in shares)		564
Employee stock purchase plan	$ 20,190		20,190
Repurchases of common stock (in shares)	(2,500)	(2,536)
Repurchases of common stock	$ (149,063)	$ (1)				(149,062)
Employee stock-based compensation	152,641		152,641
Net income	33,760					33,760
Other comprehensive loss, net	$ (5,550)				(5,550)
Ending balance (in shares) at Apr. 30, 2024	204,701	204,701
Ending balance at Apr. 30, 2024	$ 1,137,000	$ 20	$ 2,950,081	$ (2,670)	$ (24,910)	$ (1,785,521)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands		3 Months Ended
		Apr. 30, 2024	Apr. 30, 2023
Cash flows from operating activities:
Net income		$ 33,760	$ 539
Adjustments to reconcile net income provided by operating activities:
Depreciation and amortization		24,506	22,867
Amortization of deferred contract acquisition and fulfillment costs		54,212	48,230
Amortization of debt discount and transaction costs		138	1,246
Non-cash operating lease costs		4,878	5,980
Stock-based compensation expense		142,504	144,706
Deferred income taxes		1,477	1,623
Other		1,472	(831)
Changes in operating assets and liabilities:
Accounts receivable		130,639	108,281
Prepaid expenses and other current assets		(17,061)	(16,803)
Deferred contract acquisition and fulfillment costs		(63,072)	(56,526)
Other assets		1,917	(7,661)
Accounts payable		(1,163)	(9,021)
Accrued expenses and other liabilities		(3,480)	1,095
Accrued compensation		(45,048)	(21,582)
Contract liabilities		(4,973)	18,287
Operating lease liabilities		(5,880)	(6,795)
Net cash provided by operating activities		254,826	233,635
Cash flows from investing activities:
Purchases of marketable securities		(119,638)	(53,830)
Maturities of marketable securities		82,114	80,699
Purchases of strategic and other investments		(500)	0
Purchases of property and equipment		(22,753)	(19,057)
Net cash provided by (used in) investing activities		(60,777)	7,812
Cash flows from financing activities:
Repurchases of common stock		(149,062)	(40,472)
Settlement of capped calls, net of related costs		0	23,688
Payment of tax withholding obligation on net RSU settlement and ESPP purchase		(41,637)	(22,637)
Proceeds from exercise of stock options		635	127
Proceeds from employee stock purchase plan		20,190	18,390
Net cash used in financing activities		(169,874)	(20,904)
Effect of foreign exchange on cash, cash equivalents and restricted cash		(2,915)	1,011
Net increase in cash, cash equivalents and restricted cash		21,260	221,554
Cash, cash equivalents and restricted cash at beginning of period	[1]	801,499	723,201
Cash, cash equivalents and restricted cash at end of period	[1]	822,759	944,755
Supplemental disclosure:
Cash paid for interest		0	93
Cash paid for operating lease liabilities		7,689	10,861
Cash paid for income taxes		3,875	765
Non-cash investing and financing activities:
Property and equipment in accounts payable and accrued expenses and other current liabilities		2,416	2,727
Operating lease right-of-use assets exchanged for lease obligations		$ 1,837	$ 0
[1] $5.4 million and $4.4 million of restricted cash was included in Prepaid expenses and other current assets and Other assets—noncurrent at April 30, 2024 and January 31, 2024. $4.3 million and $1.3 million of restricted cash was included in Prepaid expenses and other current assets and in Other assets—noncurrent at April 30, 2023 and January 31, 2023.

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (Parenthetical) - USD ($) $ in Millions	Apr. 30, 2024	Jan. 31, 2024	Apr. 30, 2023	Jan. 31, 2023
Statement of Cash Flows [Abstract]
Restricted cash	$ 5.4	$ 4.4	$ 4.3	$ 1.3

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Organization and Description of Business Docusign, Inc. (“we,” “our”, “us”, “Docusign”, or “Company”) was incorporated in the State of Washington in April 2003. We merged with and into Docusign, Inc., a Delaware corporation, in March 2015. Docusign offers solutions that address agreement workflows and digital transformation. Docusign’s core offerings, including the world’s leading electronic signature and contract lifecycle management (“CLM”) products, allow organizations to boost productivity, accelerate contract review cycles, and transform agreement data into insights and actions while providing a better experience for their customers. Additionally, Docusign has introduced its Intelligent Agreement Management (“IAM”) platform, enabling organizations to create, commit to, and manage agreements, from virtually anywhere in the world, securely. Basis of Presentation and Principles of Consolidation Our condensed consolidated financial statements include those of Docusign, Inc. and our subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The accompanying condensed consolidated financial statements have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) for interim financial information. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the applicable rules and regulations of the Securities and Exchange Commission (“SEC”). Therefore, these unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our fiscal 2024 Annual Report on Form 10-K. Our condensed consolidated financial statements are unaudited and have been prepared on a basis consistent with that used to prepare the audited annual consolidated financial statements and, in our opinion, include all adjustments of a normal recurring nature necessary for the fair statement of our financial position, results of operations and cash flows. Our condensed consolidated balance sheet as of January 31, 2024 was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. The results of operations for the three months ended April 30, 2024 are not necessarily indicative of the results to be expected for the year ending January 31, 2025 . O ur fiscal year ends on January 3 1. References to fiscal 2025, for example, are to the fiscal year ending January 31, 2025 . Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions in the condensed consolidated financial statements and notes thereto. Significant items subject to such estimates and assumptions made by management include, but are not limited to, the determination of: • the average period of benefit associated with deferred contract acquisition costs and fulfillment costs; • the fair value of certain stock awards issued; • the useful life and recoverability of long-lived assets; • the discount rate used for operating leases; • the recognition and measurement of loss contingencies; and • the recognition, measurement and valuation of deferred income taxes. Significant Accounting Policies There have been no changes to our significant accounting policies described in our fiscal 2024 Annual Report on Form 10-K that have had a material impact on our condensed consolidated financial statements and related notes. Recent Accounting Pronouncements In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”), which enhances disclosures required for operating segments. ASU 2023-07 expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. All disclosure requirements of ASU 2023-07 are required for entities with a single reportable segment. ASU 2023-07 is effective for annual filings for the Company’s fiscal year beginning February 1, 2024, and interim filings for the fiscal year beginning February 1, 2025, and should be applied on a retrospective basis to all periods presented. We are currently evaluating the effect of adopting ASU 2023-07 on our financial statement disclosures. In December 2023, the FASB issued Accounting Standards Update 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), amending existing income tax disclosure guidance, primarily requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation. ASU 2023-09 is effective for annual reporting periods beginning after December 15, 2024, with early adoption permitted and can be applied on either a prospective or retrospective basis. We are currently evaluating the effect of adopting ASU 2023-09 on our income tax disclosures. In March 2024, the SEC adopted the final rules under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors, which requires registrants to provide certain climate-related information in their registration statements and annual reports. As it pertains to the financial statements, the final rules require the financial statement footnotes to include certain disclosures regarding the amounts of expenses (or capitalized costs) incurred that relate to severe weather events and other natural conditions, as well as other disclosures regarding the material impact on financial estimates and assumptions of severe weather events and other natural conditions or disclosed targets or disclosed targets or transition plans. It also requires disclosure of financial statement amounts related to carbon offsets and renewable energy credits. The disclosure requirements will be phased in beginning with our annual filing for the fiscal year ending January 31, 2026. In April 2024, the SEC issued an order staying these rules pending the completion of judicial review of litigation challenging the validity of the rules. We are currently evaluating the disclosure impact of adoption of the standard on our consolidated financial statements. We have not adopted accounting pronouncements during the three months ended April 30, 2024.

Revenue

Revenue	3 Months Ended
	Apr. 30, 2024
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Subscription revenue is recognized over time and accounted for approximately 97% of our revenue in each of the three month periods ended April 30, 2024 and 2023. Performance Obligations As of April 30, 2024, the amount of the transaction price allocated to remaining performance obligations for contracts greater than one year was $2.2 billion. We expect to recognize 56% of the transaction price allocated to remaining performance obligations within the 12 months following April 30, 2024 in our condensed consolidated statement of operations and comprehensive income. Contract Balances Contract assets represent amounts for which we have recognized revenue, pursuant to our revenue recognition policy, for contracts that have not yet been invoiced to our customers where there is a remaining performance obligation, typically for multi-year arrangements. Total contract assets were $12.3 million and $15.9 million as of April 30, 2024 and January 31, 2024. The change in contract assets reflects the difference in timing between our satisfaction of remaining performance obligations and our contractual right to bill our customers. Contract liabilities consist of deferred revenue and payments received in advance of performance under the contract. Such amounts are generally recognized as revenue over the contractual period. For the three months ended April 30, 2024 and 2023, we recognized revenue of $563.3 million and $510.5 million that was included in the corresponding contract liability balance at the beginning of the periods presented. We receive payments from customers based upon contractual billing schedules. We record accounts receivable when the right to consideration becomes unconditional. Payment terms on invoiced amounts are typically 30 days. Geographic Information Revenue by geography is based on the address of the customer as specified in our master subscription agreements with our customers. Revenue by geographic area was as follows: Three Months Ended April 30, (in thousands) 2024 2023 U.S. $ 512,726 $ 493,058 International 196,914 168,330 Total revenue $ 709,640 $ 661,388 The following table represents a rollforward of our deferred contract acquisition and fulfillment costs: Three Months Ended April 30, (in thousands) 2024 2023 Deferred Contract Acquisition Costs: Beginning balance $ 409,658 $ 355,389 Additions to deferred contract acquisition costs 52,088 43,239 Amortization of deferred contract acquisition costs (44,400) (35,746) Cumulative translation adjustment (1,603) 826 Ending balance $ 415,743 $ 363,708 Deferred Contract Fulfillment Costs: Beginning balance $ 22,525 $ 21,076 Additions to deferred contract fulfillment costs 10,984 13,287 Amortization of deferred contract fulfillment costs (9,812) (12,484) Cumulative translation adjustment (150) 166 Ending balance $ 23,547 $ 22,045

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Apr. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following table summarizes our financial assets that are measured at fair value on a recurring basis: April 30, 2024 (in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Level 1: Cash equivalents (1) Money market funds $ 337,891 $ — $ — $ 337,891 Level 2: Cash equivalents (1) Commercial paper 25,046 — (6) 25,040 Available-for-sale securities Commercial paper 64,466 — (129) 64,337 Corporate notes and bonds 304,672 4 (1,538) 303,138 U.S. governmental securities 41,122 1 (90) 41,033 Level 2 total 435,306 5 (1,763) 433,548 Total $ 773,197 $ 5 $ (1,763) $ 771,439 January 31, 2024 (in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Level 1: Cash equivalents (1) Money market funds $ 298,517 $ — $ — $ 298,517 Level 2: Cash equivalents (1) Commercial paper 43,845 — (9) 43,836 U.S. government agency securities 9,968 — (1) 9,967 Available-for-sale securities Commercial paper 42,958 2 (25) 42,935 Corporate notes and bonds 299,166 262 (670) 298,758 U.S. governmental securities 28,752 — (66) 28,686 Level 2 total 424,689 264 (771) 424,182 Total $ 723,206 $ 264 $ (771) $ 722,699 (1) Included in “cash and cash equivalents” in our consolidated balance sheets as of April 30, 2024 and January 31, 2024, in addition to cash of $454.5 million and $444.8 million. We use quoted prices in active markets for identical assets to determine the fair value of our Level 1 investments. The fair value of our Level 2 investments is determined using pricing based on quoted market prices or alternative market observable inputs . The fair values of our available-for-sale securities as of April 30, 2024, by remaining contractual maturities, were as follows (in thousands): Due in one year or less $ 269,400 Due in one to two years 139,108 $ 408,508 As of April 30, 2024 and January 31, 2024, securities in an unrealized loss position were, individually and in aggregate, not material. An allowance for credit losses was deemed unnecessary for these securities, given the extent of the unrealized loss positions as well as the issuers' high credit ratings and consistent payment history. We had no liabilities measured at fair value on a recurring basis as of April 30, 2024 and January 31, 2024.

Property and Equipment, Net

Property and Equipment, Net	3 Months Ended
	Apr. 30, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net Property and equipment consisted of the following: (in thousands) April 30, 2024 January 31, 2024 Computer and network equipment $ 141,464 $ 142,241 Software, including capitalized software development costs 195,390 168,584 Furniture and office equipment 18,135 18,196 Leasehold improvements 58,047 58,230 413,036 387,251 Less: Accumulated depreciation (261,585) (244,270) 151,451 142,981 Work in progress 104,285 102,192 Total $ 255,736 $ 245,173 Depreciation and amortization expense associated with property and equipment was $19.8 million and $17.8 million for the three months ended April 30, 2024 and 2023 . This included amortization expense related to capitalized internally developed software costs of $11.7 million and $6.8 million for the three months ended April 30, 2024 and 2023 . For the three months ended April 30, 2024 and 2023, we capitalized $24.7 million and $21.7 million of internally developed software, including $8.6 million and $6.8 million of capitalized stock-based compensation expense in the three months ended April 30, 2024 and 2023.

Deferred Contract Acquisition a

Deferred Contract Acquisition and Fulfillment Costs	3 Months Ended
	Apr. 30, 2024
Revenue from Contract with Customer [Abstract]
Deferred Contract Acquisition and Fulfillment Costs	Revenue Subscription revenue is recognized over time and accounted for approximately 97% of our revenue in each of the three month periods ended April 30, 2024 and 2023. Performance Obligations As of April 30, 2024, the amount of the transaction price allocated to remaining performance obligations for contracts greater than one year was $2.2 billion. We expect to recognize 56% of the transaction price allocated to remaining performance obligations within the 12 months following April 30, 2024 in our condensed consolidated statement of operations and comprehensive income. Contract Balances Contract assets represent amounts for which we have recognized revenue, pursuant to our revenue recognition policy, for contracts that have not yet been invoiced to our customers where there is a remaining performance obligation, typically for multi-year arrangements. Total contract assets were $12.3 million and $15.9 million as of April 30, 2024 and January 31, 2024. The change in contract assets reflects the difference in timing between our satisfaction of remaining performance obligations and our contractual right to bill our customers. Contract liabilities consist of deferred revenue and payments received in advance of performance under the contract. Such amounts are generally recognized as revenue over the contractual period. For the three months ended April 30, 2024 and 2023, we recognized revenue of $563.3 million and $510.5 million that was included in the corresponding contract liability balance at the beginning of the periods presented. We receive payments from customers based upon contractual billing schedules. We record accounts receivable when the right to consideration becomes unconditional. Payment terms on invoiced amounts are typically 30 days. Geographic Information Revenue by geography is based on the address of the customer as specified in our master subscription agreements with our customers. Revenue by geographic area was as follows: Three Months Ended April 30, (in thousands) 2024 2023 U.S. $ 512,726 $ 493,058 International 196,914 168,330 Total revenue $ 709,640 $ 661,388 The following table represents a rollforward of our deferred contract acquisition and fulfillment costs: Three Months Ended April 30, (in thousands) 2024 2023 Deferred Contract Acquisition Costs: Beginning balance $ 409,658 $ 355,389 Additions to deferred contract acquisition costs 52,088 43,239 Amortization of deferred contract acquisition costs (44,400) (35,746) Cumulative translation adjustment (1,603) 826 Ending balance $ 415,743 $ 363,708 Deferred Contract Fulfillment Costs: Beginning balance $ 22,525 $ 21,076 Additions to deferred contract fulfillment costs 10,984 13,287 Amortization of deferred contract fulfillment costs (9,812) (12,484) Cumulative translation adjustment (150) 166 Ending balance $ 23,547 $ 22,045

Debt

Debt	3 Months Ended
	Apr. 30, 2024
Debt Disclosure [Abstract]
Debt	Debt Convertible Senior Notes In September 2018, we issued $575.0 million in aggregate principal amount of the 0.5% Convertible Senior Notes due in 2023 (“2023 Notes”). The net proceeds from the issuance of the 2023 Notes were $560.8 million after deducting the initial purchasers’ discounts and transaction costs. In January 2021, we issued $690.0 million in aggregate principal amount of the 0% Convertible Senior Notes due in 2024 (“2024 Notes,” and together with the 2023 Notes, the “Notes”). The net proceeds from the issuance of the 2024 Notes were $677.3 million after deducting the initial purchasers’ discounts and transaction costs. The 2023 Notes and 2024 Notes were extinguished, and all outstanding amounts were repaid in full during the third and fourth quarters of fiscal 2024, respectively. We repaid in cash $37.1 million and $689.9 million in aggregate principal amount of the 2023 Notes and 2024 Notes. The effective interest rate on the 2023 Notes was 1.0%. The effective interest rate on the 2024 Notes was 0.6%. Interest expense recognized related to the Notes was as follows: Three Months Ended April 30, (in thousands) 2024 2023 Contractual interest expense $ — $ 357 Amortization of transaction costs — 1,109 Total $ — $ 1,466 Capped Calls To minimize the potential economic dilution to our common stock upon conversion of the Notes, we entered into privately negotiated capped call transactions (“Capped Calls”) with certain counterparties. In the first quarter of fiscal 2024, we unwound $23.7 million of the Capped Calls in relation to our 2023 Notes and received cash from the counterparties. All remaining Capped Calls associated with the 2023 Notes and 2024 Notes expired during the third and fourth quarters of fiscal 2024, respectively. Impact on Net Income Per Share In periods when we have net income, the shares of our common stock subject to the Notes outstanding during the period are included in our diluted earnings per share under the if-converted method. In the three months ended April 30, 2023, the Capped Calls were excluded from the calculation of diluted earnings per share, as they were antidilutive. Revolving Credit Facility In January 2021, we entered into a credit agreement, as subsequently amended in May 2023, with a syndicate of banks. The credit agreement extended a senior secured revolving credit facility (the “Credit Facility”) to us in an aggregate principal amount of $500.0 million, which amount may be increased by an additional $250.0 million subject to the terms of the credit agreement. We may use the proceeds of future borrowings under the credit facility to finance working capital, for capital expenditures and for other general corporate purposes, including permitted acquisitions. The Credit Facility matures in January 2026 and requires us to comply with customary affirmative and negative covenants. We were in compliance with all covenants as of April 30, 2024. As of April 30, 2024, there were no outstanding borrowings under the Credit Facility. The Credit Facility is subject to customary fees for loan facilities of this type, including ongoing commitment fees at a rate between 0.25% and 0.30% per annum on the daily undrawn balance.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Apr. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies As of April 30, 2024, we had unused letters of credit outstanding totaling $1.3 million, the majority of which are associated with our various operating leases. We have entered into certain noncancelable contractual arrangements that require future purchases of goods and services. These arrangements primarily relate to cloud infrastructure support and sales and marketing activities. As of April 30, 2024, our future noncancelable minimum payments due under these contractual obligations with a remaining term of more than one year were as follows: Fiscal Period: Amount (in thousands) 2025, remainder $ 37,798 2026 55,097 2027 8,820 2028 1,663 2029 1,138 Thereafter 484 Total $ 105,000 We entered into agreements with public cloud computing service providers with minimum commitments through fiscal 2027 and 2028. As of April 30, 2024 our remaining commitments under these agreements are $17.3 million and $108.4 million respectively, which are excluded from the table above. Indemnification We enter into indemnification provisions under our agreements with customers and other companies in the ordinary course of business, including business partners, contractors and parties performing our research and development. Pursuant to these arrangements, we agree to indemnify and defend the indemnified party for certain claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party claims because of our activities. The duration of these indemnification agreements is generally perpetual. The maximum potential amount of future payments we could be required to make under these indemnification clauses or agreements is not determinable. Historically, we have not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, we believe the fair value of these indemnification agreements is not material as of April 30, 2024, and January 31, 2024. We maintain commercial general liability insurance and product liability insurance to offset certain of our potential liabilities under these indemnification agreements. We have entered into indemnification agreements with each of our directors, executive officers and certain other officers. These agreements require us to indemnify such individuals, to the fullest extent permitted by Delaware law, for certain liabilities to which they may become subject as a result of their affiliation with us. Claims and Litigation From time to time, we may be subject to legal proceedings, claims and litigation made against us in the ordinary course of business. Legal costs associated with litigation are expensed as incurred. We believe the final outcome of these matters, including the case described below, will not have a material adverse effect on our business, consolidated financial position, results of operations or cash flows. Docusign, Inc. Securities Litigation and Related Derivative Litigation On February 8, 2022, a putative securities class action was filed in the U.S. District Court for the Northern District of California, captioned Weston v. Docusign, Inc., et al., Case No. 3:22-cv-00824, naming Docusign and certain of our then-current and former officers as defendants. An amended complaint was filed on July 8, 2022. As amended, the suit purports to allege claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and Rule 10b-5 promulgated thereunder, based on allegedly false and misleading statements about our business and prospects during the course of the COVID-19 pandemic. As amended, the suit is purportedly brought on behalf of purchasers of our securities between June 4, 2020 and June 9, 2022. Our motion to dismiss the case at the pleading stage was denied by the U.S. District Court on April 18, 2023 and the suit is now proceeding. An earlier action alleging similar claims against the same defendants, captioned Collins v. Docusign, Inc., et al., Case No. 3:22-cv-00851, filed in the Eastern District of New York and subsequently transferred to the Northern District of California, was voluntarily dismissed on February 14, 2022. Eight putative shareholder derivative cases have been filed containing allegations based on or similar to those in the securities class action (Weston). The cases were filed on May 17, 2022, in the U.S. District Court for the District of Delaware, captioned Pottetti v. Springer, et al., Case No. 1:22-cv-00652; on May 19, 2022, in the U.S. District Court for the Northern District of California, captioned Lapin v. Springer, et al., Case No. 3:22-cv-02980; on May 20, 2022, in the U.S. District Court for the Northern District of California, captioned Votto v. Springer, et al., Case No. 3:22-cv-02987; on September 20, 2022, in the U.S. District Court for the Northern District of California, captioned Fox v. Springer, et al., Case No. 3:22-cv-05343; on March 7, 2024, in the Delaware Court of Chancery, captioned Roy v. Alhadeff, et al., Case No. C.A. 2024-0223-PAF; on April 9, 2024, in the U.S. District Court for the Northern District of California, captioned Alexander v. Springer, et al., Case No. 3:24-cv-02139; on April 11, 2024, in the Delaware Court of Chancery, captioned Ingrao v. Beer, et al., Case No. C.A. 2024-0382-PAF; and on May 28, 2024, in the Delaware Court of Chancery, captioned Jordan v. Springer, et al., Case No. C.A. 2024-0564-PAF. Each case is allegedly brought on the Company’s behalf. The suits name the Company as a nominal defendant and, depending on the particular case, the members of our board of directors or, in certain instances, then-current or former officers, as defendants. While the complaints vary, they are based largely on the same underlying allegations as the securities class action suit described above (Weston), as well as, in certain instances, alleged insider trading. Collectively, these lawsuits purport to assert claims for, among other things, breach of fiduciary duty, aiding and abetting such breach, corporate waste, gross mismanagement, unjust enrichment, and under Sections 10(b) and 21D of the Securities Exchange Act of 1934. The complaints seek to recover unspecified damages and other relief on the Company’s behalf. By court order dated July 19, 2022, the first two cases in the Northern District of California (Lapin and Votto) have been consolidated and stayed in light of the securities class action and no response to the complaints in the action will be due unless and until the stay is lifted. The third case in the Northern District of California (Fox) was related to the other derivative suits and assigned to the same judge, and was similarly stayed by order of the court on December 2, 2022. The most recent case in the Northern District of California (Alexander) was also related to the other derivative suits and assigned to the same judge, and subsequently consolidated with Lapin and Votto and stayed by order of the court on May 8, 2024. The Delaware suit (Pottetti) was voluntarily dismissed on September 1, 2022, and then re-filed in the Delaware Court of Chancery on September 22, 2022, under the caption Pottetti v. Springer, et al., Case No. C.A. 2022-0852-PAF. The Delaware Court of Chancery issued an order on September 30, 2022, staying the action in light of the securities class action. On May 28, 2024, plaintiff filed a notice seeking to voluntarily dismiss the Delaware Court of Chancery Pottetti action. An order of dismissal has not yet issued. Similar to the stay in Pottetti, we anticipate seeking a stay of the newly filed suits (Roy, Ingrao, and Jordan) in light of the securities class action, such that no response to the complaints would be due unless and until the stay is lifted. Docusign Civil Litigation On October 25, 2022, an action was filed in the Delaware Court of Chancery, captioned Daniel D. Springer v. Mary Agnes Wilderotter and Docusign, Inc., Civil Action No. 2022-0963-LWW, concerning Mr. Springer’s resignation from our board of directors. Mr. Springer’s complaint sought relief determining that he did not resign from his position on our board of directors and remains a director, and for an award of attorneys’ fees and costs associated with the civil action. To avoid the cost and distraction of further litigation with Mr. Springer, the Company offered to stipulate to entry of judgment in favor of Mr. Springer as to his disputed resignation and his status as a member of our board of directors. Following our offer, on January 11, 2023, the Chancery Court issued an order declaring and confirming that (i) Mr. Springer has not resigned from the board of directors and (ii) Mr. Springer is currently a member of the board of directors. Mr. Springer subsequently filed a motion seeking payment of his attorneys’ fees. The Court of Chancery dismissed the case after Mr. Springer withdrew his motion for attorneys’ fees earlier this year. In addition, on January 26, 2023, Mr. Springer delivered a demand for arbitration before JAMS, a private alternative dispute resolution firm, captioned Daniel D. Springer v. Docusign, Inc. and Mary Agnes Wilderotter. In the demand, Mr. Springer alleges that he was wrongfully terminated as Chief Executive Officer; asserts related claims against Docusign and Ms. Wilderotter, including defamation, withholding promised compensation and breach of contract; and seeks unspecified damages and other relief, including his attorneys’ fees from the Delaware litigation. The arbitration hearing for this case took place from March 11-15, 2024, and the parties have completed post-hearing briefings. A final order from the arbitrator is expected on or before July 12, 2024.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Apr. 30, 2024
Equity [Abstract]
Stockholders' Equity	Stockholders' Equity Equity Incentive Plans We maintain three stock-based compensation plans: the 2018 Equity Incentive Plan (the “2018 Plan”), the Amended and Restated 2011 Equity Incentive Plan and the Amended and Restated 2003 Stock Plan. As of April 30, 2024, 47.0 million shares of our common stock were available for issuance under the 2018 Plan. Restricted Stock Units Restricted stock unit (“RSU”) activity for the three months ended April 30, 2024 was as follows: (in thousands, except per share data) Number of Units Weighted-Average Grant Date Fair Value Unvested at January 31, 2024 26,700 $ 60.70 Granted 1,192 54.47 Vested (2,136) 73.52 Canceled (1,469) 64.35 Unvested at April 30, 2024 24,287 $ 58.79 As of April 30, 2024, our total unrecognized compensation cost related to RSUs was $1.0 billion. We expect to recognize this expense over the remaining weighted-average period of approximately 2.88 years. As of April 30, 2024, the grant date fair value of unvested RSUs subject to market-based and performance-based vesting conditions (“PSU”) was $116.6 million. The number of RSUs granted or canceled included in the table above reflects shares that could be eligible to vest at 100% of target for PSUs and includes adjustments for over or under achievement for PSUs granted in prior periods. Stock Options Option activity for the three months ended April 30, 2024 was as follows: (in thousands, except years and per share data) Number of Options Weighted-Average Exercise Price Per Share Weighted-Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at January 31, 2024, all vested and exercisable 1,385 $ 17.39 2.63 $ 60,117 Exercised (56) 11.43 Outstanding at April 30, 2024, all vested and exercisable 1,329 $ 17.64 2.48 $ 51,643 As of April 30, 2024, there was no remaining unrecognized compensation cost related to stock option grants. Employee Stock Purchase Plan The Employee Stock Purchase Plan (“ESPP”) allows eligible employees to purchase shares of our common stock at a discounted price, normally through payroll deductions, subject to the terms of the ESPP and applicable law. As of April 30, 2024, 12.1 million shares of our common stock were reserved for issuance under the ESPP. Compensation expense related to the ESPP was $3.0 million and $4.2 million for the three months ended April 30, 2024 and 2023. Stock Repurchase Program In March 2022, our board of directors authorized a stock repurchase program of up to $200.0 million of our outstanding common stock. Subsequently, in September 2023, our board of directors authorized an increase to its existing stock repurchase program for an additional amount of up to $300.0 million of our outstanding common stock. During the three months ended April 30, 2024, we repurchased and cancelled 2.5 million shares of common stock at an average price of $58.78 per share, for an aggregate amount of $149.1 million. During the three months ended April 30, 2023, we repurchased and cancelled 0.7 million shares of common stock at an average price of $57.06 per share, for an aggregate amount of $40.5 million.

Restructuring and Other Related

Restructuring and Other Related Charges	3 Months Ended
	Apr. 30, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Other Related Charges	Restructuring 2024 Restructuring Plan During the first quarter of fiscal 2024 , our board of directors authorized a restructuring plan (the “2024 Restructuring Plan”) designed to support our growth, scale and profitability objectives. We incurred costs associated with the 2024 Restructuring Plan related to employee termination benefits and other costs mainly in the first quarter of fiscal 2024. As of the second quarter of fiscal 2024, the 2024 Restructuring Plan had been substantially completed. 2025 Restructuring Plan During the first quarter of fiscal 2025 , our board of directors authorized a restructuring plan (the “2025 Restructuring Plan”) designed to strengthen and support our financial and operational efficiency while continuing to invest in product and related initiatives. We incurred costs associated with the 2025 Restructuring Plan related to employee termination benefits and other costs mainly in the first quarter of fiscal 2025 and expect that the execution of the 2025 Restructuring Plan will be substantially complete by the end of the second quarter of fiscal 2025. These amounts are recorded to the Restructuring and other related charges within our consolidated statements of operations and comprehensive income as they are incurred. For the three months ended April 30, 2024, restructuring and other related charges were $29.1 million for employee termination benefits, including stock-based compensation expense of $4.6 million. For the three months ended April 30, 2023, restructuring and other related charges were $28.8 million, and primarily composed of $27.7 million for employee termination benefits, which included stock-based compensation expense of $5.0 million. Restructuring liability activities during the three months ended April 30, 2024: (in thousands) January 31, 2024 Accruals Cash Payments April 30, 2024 2024 Restructuring Plan Other 122 — (122) — Total $ 122 $ — $ (122) $ — 2025 Restructuring Plan Employee termination benefits $ — $ 24,413 $ (22,255) $ 2,158 Total $ — $ 24,413 $ (22,255) $ 2,158

Net Income per Share Attributab

Net Income per Share Attributable to Common Stockholders	3 Months Ended
	Apr. 30, 2024
Earnings Per Share [Abstract]
Net Income per Share Attributable to Common Stockholders	Net Income per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net income per share attributable to common stockholders for periods presented: Three Months Ended April 30, (in thousands, except per share data) 2024 2023 Numerator: Net income attributable to common stockholders, basic $ 33,760 $ 539 Add: Interest expense on convertible senior notes — 357 Net income attributable to common stockholders, diluted $ 33,760 $ 896 Denominator: Weighted-average common shares outstanding, basic 205,870 202,631 Effect of dilutive securities 4,026 5,440 Weighted-average common shares outstanding, diluted 209,896 208,071 Net income per share attributable to common stockholders: Basic $ 0.16 $ 0.00 Diluted $ 0.16 $ 0.00 Outstanding potentially dilutive securities that were excluded from the diluted per share calculations because they would have been antidilutive are as follows: Three Months Ended April 30, (in thousands) 2024 2023 RSUs 4,480 7,191 ESPP 114 35 Total antidilutive securities 4,594 7,226

Income Taxes

Income Taxes	3 Months Ended
	Apr. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our tax provision or benefit from income taxes for interim periods is determined using an estimate of our annual effective tax rate as prescribed under Accounting Standards Codification (“ASC”) 740, “ Income Taxes ”, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, we update our estimate of the annual effective tax rate, and if our estimated tax rate changes, we make a cumulative adjustment, which results in a provision or benefit from income taxes in current or subsequent quarters. There were no material discrete items in the quarter. Our income tax provision was $2.8 million and $5.1 million for the three months ended April 30, 2024 and 2023, respectively. The change was primarily due to the decrease of the annual effective tax rate driven by the increase of the forecasted annual pretax earnings.While annual pretax earnings are expected to increase, our income tax provision is expected to remain relatively flat as we have net operating losses and research tax credits in the U.S. to offset an increase in our U.S. tax liability. We review the likelihood that we will realize the benefit of our deferred tax assets and, therefore, the need for valuation allowances, on a quarterly basis. We maintain a valuation allowance against certain deferred tax assets, including all U.S. consolidated group deferred tax assets and certain foreign deferred tax assets as a result of our history of losses in the U.S. and certain foreign jurisdictions, and the variability and uncertainty of our operating results. In the event we determine our deferred tax assets are realizable based on our assessment of relevant factors, an adjustment to the valuation allowance may increase income in the period such determination is made. Given our current earnings and anticipated future earnings, we believe that there is a reasonable possibility that during fiscal year 2025, sufficient positive evidence may become available to allow us to reach a conclusion that some portion of or the entire U.S. valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of material U.S. federal and state deferred tax assets and a corresponding decrease to income tax expense estimated to be $750 million to $850 million in the period the release is recorded. The exact timing and amount of the valuation allowance release are subject to change based on the level of sustained U.S. profitability that we are able to actually achieve, as well as the amount of tax deductible stock compensation dependent upon our publicly traded stock price, market acceptance for our products and solutions offerings such as our new IAM platform, and macroeconomic conditions, among other factors. As of April 30, 2024, our gross unrecognized tax benefits totaled $62.7 million, excluding related accrued interest and penalties, of which $10.8 million would impact the effective tax rate if recognized. Our policy is to account for interest and penalties related to uncertain tax positions as a component of income tax provision. We do not expect material changes to our gross unrecognized tax benefits within the next 12 months.

Subsequent Events

Subsequent Events	3 Months Ended
	Apr. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events On May 5, 2024, Docusign agreed to acquire DocuSmart, Inc. d/b/a Lexion ("Lexion") pursuant to an Agreement and Plan of Merger by and among Docusign, Lexion, Laser Merger Sub, Inc. and Fortis Advisors LLC as stockholders' representative ("Merger Agreement"). The Merger Agreement provides for the acquisition of all outstanding equity interests of Lexion in exchange for consideration of approximately $165 million in cash, subject to adjustments. In connection with the acquisition, we also issued to certain Lexion employees RSUs which will vest subject to each employee’s respective continued employment. Lexion offers an AI-powered contract management platform which features intelligent contract repository and agreement workflow automation and reporting. The acquisition closed on May 31, 2024. Given the timing of the completion of the acquisition, we are currently in the process of valuing the assets acquired and liabilities assumed in the acquisition. As a result, we are unable to provide the amounts recognized as of the acquisition date for the major classes of assets acquired and liabilities assumed and other disclosures. In May 2024, our board of directors authorized an increase to our existing stock repurchase program for an additional amount of up to $1.0 billion of our outstanding common stock. The program has no minimum purchase commitment and no mandated end date. The repurchase program may be suspended or discontinued at any time at our discretion. The timing and amount of any repurchased common stock will be determined by management based on its evaluation of market conditions and other factors.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Pay vs Performance Disclosure
Net income	$ 33,760	$ 539

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Apr. 30, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	Name Title Adoption Date Earliest Sale Date Expiration Date Aggregate # of securities to be sold Aggregate # of securities to be purchased Robert Chatwani President, GM, Growth March 25, 2024 June 24, 2024 March 31, 2025 Up to 120,038 N/A Stephen Shute (1) President, WW Field Operations April 9, 2024 July 9, 2024 July 31, 2025 Up to 218,521 N/A Daniel Springer Director April 8, 2024 August 1, 2024 April 9, 2025 Up to 716,070 N/A 1. The aggregate # of securities to be sold under Mr. Shute’s plan includes the maximum payout for certain unvested PSUs. Each of the 10b5-1 plans in the above table included a representation from the director or officer to the broker administering the plan that such individual was not in possession of any material nonpublic information regarding the Company or the securities subject to the plan. A similar representation was made to the Company in connection with the adoption of the plan under the Company’s insider trading policy. Those representations were made as of the date of adoption of the 10b5-1 plan, and speak only as of that date. In making those representations, there is no assurance with respect to any material nonpublic information of which the director or officer was unaware, or with respect to any material nonpublic information acquired by the director or officer or the Company after the date of the representation.
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Robert Chatwani [Member]
Trading Arrangements, by Individual
Name	Robert Chatwani
Title	President, GM, Growth
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	March 25, 2024
Arrangement Duration	280 days
Aggregate Available	120,038
Stephen Shute [Member]
Trading Arrangements, by Individual
Name	Stephen Shute
Title	President, WW Field Operations
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	April 9, 2024
Arrangement Duration	387 days
Aggregate Available	218,521
Daniel Springer [Member]
Trading Arrangements, by Individual
Name	Daniel Springer
Title	Director
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	April 8, 2024
Arrangement Duration	251 days
Aggregate Available	716,070

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2024
Accounting Policies [Abstract]
Principles of Consolidation	Our condensed consolidated financial statements include those of Docusign, Inc. and our subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The accompanying condensed consolidated financial statements have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) for interim financial information. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the applicable rules and regulations of the Securities and Exchange Commission (“SEC”). Therefore, these unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our fiscal 2024 Annual Report on Form 10-K.
Basis of Presentation	Our condensed consolidated financial statements are unaudited and have been prepared on a basis consistent with that used to prepare the audited annual consolidated financial statements and, in our opinion, include all adjustments of a normal recurring nature necessary for the fair statement of our financial position, results of operations and cash flows. Our condensed consolidated balance sheet as of January 31, 2024 was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. The results of operations for the three months ended April 30, 2024 are not necessarily indicative of the results to be expected for the year ending January 31, 2025 .
Fiscal Year	O ur fiscal year ends on January 3 1. References to fiscal 2025, for example, are to the fiscal year ending January 31, 2025 .
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions in the condensed consolidated financial statements and notes thereto. Significant items subject to such estimates and assumptions made by management include, but are not limited to, the determination of: • the average period of benefit associated with deferred contract acquisition costs and fulfillment costs; • the fair value of certain stock awards issued; • the useful life and recoverability of long-lived assets; • the discount rate used for operating leases; • the recognition and measurement of loss contingencies; and • the recognition, measurement and valuation of deferred income taxes.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”), which enhances disclosures required for operating segments. ASU 2023-07 expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. All disclosure requirements of ASU 2023-07 are required for entities with a single reportable segment. ASU 2023-07 is effective for annual filings for the Company’s fiscal year beginning February 1, 2024, and interim filings for the fiscal year beginning February 1, 2025, and should be applied on a retrospective basis to all periods presented. We are currently evaluating the effect of adopting ASU 2023-07 on our financial statement disclosures. In December 2023, the FASB issued Accounting Standards Update 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), amending existing income tax disclosure guidance, primarily requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation. ASU 2023-09 is effective for annual reporting periods beginning after December 15, 2024, with early adoption permitted and can be applied on either a prospective or retrospective basis. We are currently evaluating the effect of adopting ASU 2023-09 on our income tax disclosures. In March 2024, the SEC adopted the final rules under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors, which requires registrants to provide certain climate-related information in their registration statements and annual reports. As it pertains to the financial statements, the final rules require the financial statement footnotes to include certain disclosures regarding the amounts of expenses (or capitalized costs) incurred that relate to severe weather events and other natural conditions, as well as other disclosures regarding the material impact on financial estimates and assumptions of severe weather events and other natural conditions or disclosed targets or disclosed targets or transition plans. It also requires disclosure of financial statement amounts related to carbon offsets and renewable energy credits. The disclosure requirements will be phased in beginning with our annual filing for the fiscal year ending January 31, 2026. In April 2024, the SEC issued an order staying these rules pending the completion of judicial review of litigation challenging the validity of the rules. We are currently evaluating the disclosure impact of adoption of the standard on our consolidated financial statements. We have not adopted accounting pronouncements during the three months ended April 30, 2024.

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Apr. 30, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Revenues by Geographic Area	Revenue by geographic area was as follows: Three Months Ended April 30, (in thousands) 2024 2023 U.S. $ 512,726 $ 493,058 International 196,914 168,330 Total revenue $ 709,640 $ 661,388

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Apr. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following table summarizes our financial assets that are measured at fair value on a recurring basis: April 30, 2024 (in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Level 1: Cash equivalents (1) Money market funds $ 337,891 $ — $ — $ 337,891 Level 2: Cash equivalents (1) Commercial paper 25,046 — (6) 25,040 Available-for-sale securities Commercial paper 64,466 — (129) 64,337 Corporate notes and bonds 304,672 4 (1,538) 303,138 U.S. governmental securities 41,122 1 (90) 41,033 Level 2 total 435,306 5 (1,763) 433,548 Total $ 773,197 $ 5 $ (1,763) $ 771,439 January 31, 2024 (in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Level 1: Cash equivalents (1) Money market funds $ 298,517 $ — $ — $ 298,517 Level 2: Cash equivalents (1) Commercial paper 43,845 — (9) 43,836 U.S. government agency securities 9,968 — (1) 9,967 Available-for-sale securities Commercial paper 42,958 2 (25) 42,935 Corporate notes and bonds 299,166 262 (670) 298,758 U.S. governmental securities 28,752 — (66) 28,686 Level 2 total 424,689 264 (771) 424,182 Total $ 723,206 $ 264 $ (771) $ 722,699 (1) Included in “cash and cash equivalents” in our consolidated balance sheets as of April 30, 2024 and January 31, 2024, in addition to cash of $454.5 million and $444.8 million.
Schedule of Fair Value of Available-for-sale Marketable Securities by Remaining Contractual Maturities	The fair values of our available-for-sale securities as of April 30, 2024, by remaining contractual maturities, were as follows (in thousands): Due in one year or less $ 269,400 Due in one to two years 139,108 $ 408,508

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	3 Months Ended
	Apr. 30, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment consisted of the following: (in thousands) April 30, 2024 January 31, 2024 Computer and network equipment $ 141,464 $ 142,241 Software, including capitalized software development costs 195,390 168,584 Furniture and office equipment 18,135 18,196 Leasehold improvements 58,047 58,230 413,036 387,251 Less: Accumulated depreciation (261,585) (244,270) 151,451 142,981 Work in progress 104,285 102,192 Total $ 255,736 $ 245,173

Deferred Contract Acquisition_2

Deferred Contract Acquisition and Fulfillment Costs (Tables)	3 Months Ended
	Apr. 30, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Deferred Contract Acquisition and Fulfillment Costs	The following table represents a rollforward of our deferred contract acquisition and fulfillment costs: Three Months Ended April 30, (in thousands) 2024 2023 Deferred Contract Acquisition Costs: Beginning balance $ 409,658 $ 355,389 Additions to deferred contract acquisition costs 52,088 43,239 Amortization of deferred contract acquisition costs (44,400) (35,746) Cumulative translation adjustment (1,603) 826 Ending balance $ 415,743 $ 363,708 Deferred Contract Fulfillment Costs: Beginning balance $ 22,525 $ 21,076 Additions to deferred contract fulfillment costs 10,984 13,287 Amortization of deferred contract fulfillment costs (9,812) (12,484) Cumulative translation adjustment (150) 166 Ending balance $ 23,547 $ 22,045

Debt (Tables)

Debt (Tables)	3 Months Ended
	Apr. 30, 2024
Debt Disclosure [Abstract]
Schedule of Interest Expense	Interest expense recognized related to the Notes was as follows: Three Months Ended April 30, (in thousands) 2024 2023 Contractual interest expense $ — $ 357 Amortization of transaction costs — 1,109 Total $ — $ 1,466

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Apr. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Contractual Obligations	As of April 30, 2024, our future noncancelable minimum payments due under these contractual obligations with a remaining term of more than one year were as follows: Fiscal Period: Amount (in thousands) 2025, remainder $ 37,798 2026 55,097 2027 8,820 2028 1,663 2029 1,138 Thereafter 484 Total $ 105,000

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Apr. 30, 2024
Equity [Abstract]
Schedule of RSU Activity	Restricted stock unit (“RSU”) activity for the three months ended April 30, 2024 was as follows: (in thousands, except per share data) Number of Units Weighted-Average Grant Date Fair Value Unvested at January 31, 2024 26,700 $ 60.70 Granted 1,192 54.47 Vested (2,136) 73.52 Canceled (1,469) 64.35 Unvested at April 30, 2024 24,287 $ 58.79
Schedule of Options Activity	Option activity for the three months ended April 30, 2024 was as follows: (in thousands, except years and per share data) Number of Options Weighted-Average Exercise Price Per Share Weighted-Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at January 31, 2024, all vested and exercisable 1,385 $ 17.39 2.63 $ 60,117 Exercised (56) 11.43 Outstanding at April 30, 2024, all vested and exercisable 1,329 $ 17.64 2.48 $ 51,643

Restructuring and Other Relat_2

Restructuring and Other Related Charges (Tables)	3 Months Ended
	Apr. 30, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Liabilities	Restructuring liability activities during the three months ended April 30, 2024: (in thousands) January 31, 2024 Accruals Cash Payments April 30, 2024 2024 Restructuring Plan Other 122 — (122) — Total $ 122 $ — $ (122) $ — 2025 Restructuring Plan Employee termination benefits $ — $ 24,413 $ (22,255) $ 2,158 Total $ — $ 24,413 $ (22,255) $ 2,158

Net Income per Share Attribut_2

Net Income per Share Attributable to Common Stockholders (Tables)	3 Months Ended
	Apr. 30, 2024
Earnings Per Share [Abstract]
Schedule of Calculation of Basic and Diluted Net Income Per Share Attributable to Common Stockholders	The following table presents the calculation of basic and diluted net income per share attributable to common stockholders for periods presented: Three Months Ended April 30, (in thousands, except per share data) 2024 2023 Numerator: Net income attributable to common stockholders, basic $ 33,760 $ 539 Add: Interest expense on convertible senior notes — 357 Net income attributable to common stockholders, diluted $ 33,760 $ 896 Denominator: Weighted-average common shares outstanding, basic 205,870 202,631 Effect of dilutive securities 4,026 5,440 Weighted-average common shares outstanding, diluted 209,896 208,071 Net income per share attributable to common stockholders: Basic $ 0.16 $ 0.00 Diluted $ 0.16 $ 0.00
Schedule of Antidilutive Securities	Outstanding potentially dilutive securities that were excluded from the diluted per share calculations because they would have been antidilutive are as follows: Three Months Ended April 30, (in thousands) 2024 2023 RSUs 4,480 7,191 ESPP 114 35 Total antidilutive securities 4,594 7,226

Revenue - Narrative (Details)

Revenue - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2024
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligations	$ 2,200
Contract assets	12.3		$ 15.9
Revenue recognized that was included in contract liability balance at the beginning of the period	$ 563.3	$ 510.5
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-05-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage	56%
Remaining performance obligations, period of recognition	12 months
Product Concentration Risk | Revenue | Subscription
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Concentration risk percentage	97%	97%

Revenue - Schedule of Revenues

Revenue - Schedule of Revenues by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 709,640	$ 661,388
U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	512,726	493,058
International
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 196,914	$ 168,330

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	$ 773,197	$ 723,206
Gross Unrealized Gains	5	264
Gross Unrealized Losses	(1,763)	(771)
Estimated Fair Value	771,439	722,699
Cash	454,500	444,800
Level 2 | Available-for-sale securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	435,306	424,689
Gross Unrealized Gains	5	264
Gross Unrealized Losses	(1,763)	(771)
Estimated Fair Value	433,548	424,182
Money market funds | Level 1 | Cash Equivalents
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	337,891	298,517
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	337,891	298,517
Commercial paper | Level 2 | Cash Equivalents
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	25,046	43,845
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(6)	(9)
Estimated Fair Value	25,040	43,836
Commercial paper | Level 2 | Available-for-sale securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	64,466	42,958
Gross Unrealized Gains	0	2
Gross Unrealized Losses	(129)	(25)
Estimated Fair Value	64,337	42,935
Corporate notes and bonds | Level 2 | Available-for-sale securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	304,672	299,166
Gross Unrealized Gains	4	262
Gross Unrealized Losses	(1,538)	(670)
Estimated Fair Value	303,138	298,758
U.S. governmental securities | Level 2 | Cash Equivalents
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost		9,968
Gross Unrealized Gains		0
Gross Unrealized Losses		(1)
Estimated Fair Value		9,967
U.S. governmental securities | Level 2 | Available-for-sale securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	41,122	28,752
Gross Unrealized Gains	1	0
Gross Unrealized Losses	(90)	(66)
Estimated Fair Value	$ 41,033	$ 28,686

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Fair Value of Available-for-sale Marketable Securities by Remaining Contractual Maturities (Details) - Short-term Investments $ in Thousands	Apr. 30, 2024 USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Due in one year or less	$ 269,400
Due in one to two years	139,108
Total available-for-sale securities	$ 408,508

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2024
Property, Plant and Equipment [Line Items]
Property and equipment, net	$ 255,736		$ 245,173
Depreciation expense	19,800	$ 17,800
Capitalized computer software, amortization	11,700	6,800
Capitalized software costs	24,700	21,700
Capitalized stock-based compensation	8,600	$ 6,800
Property and equipment, excluding work in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	413,036		387,251
Less: Accumulated depreciation	(261,585)		(244,270)
Property and equipment, net	151,451		142,981
Computer and network equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	141,464		142,241
Software, including capitalized software development costs
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	195,390		168,584
Furniture and office equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	18,135		18,196
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	58,047		58,230
Work in progress
Property, Plant and Equipment [Line Items]
Property and equipment, net	$ 104,285		$ 102,192

Deferred Contract Acquisition_3

Deferred Contract Acquisition and Fulfillment Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Capitalized Contract Cost, Net [Roll Forward]
Amortization of deferred contract acquisition costs	$ (54,212)	$ (48,230)
Deferred Contract Acquisition Costs:
Capitalized Contract Cost, Net [Roll Forward]
Beginning balance	409,658	355,389
Additions to deferred contract acquisition costs	52,088	43,239
Amortization of deferred contract acquisition costs	(44,400)	(35,746)
Cumulative translation adjustment	(1,603)	826
Ending balance	415,743	363,708
Deferred Contract Fulfillment Costs:
Capitalized Contract Cost, Net [Roll Forward]
Beginning balance	22,525	21,076
Additions to deferred contract acquisition costs	10,984	13,287
Amortization of deferred contract acquisition costs	(9,812)	(12,484)
Cumulative translation adjustment	(150)	166
Ending balance	$ 23,547	$ 22,045

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)	1 Months Ended		3 Months Ended
	Jan. 31, 2021	Sep. 30, 2018	Apr. 30, 2024	Jan. 31, 2024	Oct. 31, 2023	May 31, 2023	Apr. 30, 2023
Convertible Senior Notes Due 2023 | Convertible Debt
Debt Conversion [Line Items]
Principal on face amount of debt		$ 575,000,000
Debt interest rate percentage		0.50%
Proceeds from issuance of debt		$ 560,800,000
Repayments of convertible senior notes					$ 37,100,000
Debt instrument, effective interest rate			1%
Convertible Senior Notes Due 2023 | Convertible Debt | Capped Calls
Debt Conversion [Line Items]
Settlement of capped calls, net of related costs							$ 23,700,000
Convertible Senior Notes Due 2024 | Convertible Debt
Debt Conversion [Line Items]
Principal on face amount of debt	$ 690,000,000
Debt interest rate percentage	0%
Proceeds from issuance of debt	$ 677,300,000
Repayments of convertible senior notes				$ 689,900,000
Debt instrument, effective interest rate			0.60%
Credit Facility | Revolving Credit Facility
Debt Conversion [Line Items]
Line of credit, maximum borrowing capacity						$ 500,000,000
Line of credit, additional borrowing amount						$ 250,000,000
Carrying value of debt			$ 0
Credit Facility | Revolving Credit Facility | Minimum
Debt Conversion [Line Items]
Line of credit, commitment fee percentage on undrawn balance			0.25%
Credit Facility | Revolving Credit Facility | Maximum
Debt Conversion [Line Items]
Line of credit, commitment fee percentage on undrawn balance			0.30%

Debt - Schedule of Interest Exp

Debt - Schedule of Interest Expense (Details) - Convertible Debt - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Debt Instrument [Line Items]
Contractual interest expense	$ 0	$ 357
Amortization of transaction costs	0	1,109
Total	$ 0	$ 1,466

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Millions	Apr. 30, 2024 USD ($) putative_case	Jul. 19, 2022 stayed_case
Other Commitments [Line Items]
Letters of credit outstanding	$ 1.3
Number of putative shareholder derivative cases filed | putative_case	8
Number of cases stayed by court order | stayed_case		2
Cloud Computing Service Provider, Agreement Through Fiscal 2027
Other Commitments [Line Items]
Minimum commitment	$ 17.3
Cloud Computing Service Provider, Agreement Through Fiscal 2028
Other Commitments [Line Items]
Minimum commitment	$ 108.4

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of Contractual Obligations (Details) $ in Thousands	Apr. 30, 2024 USD ($)
Purchase Obligation, Fiscal Year Maturity [Abstract]
2025, remainder	$ 37,798
2026	55,097
2027	8,820
2028	1,663
2029	1,138
Thereafter	484
Total	$ 105,000

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details) $ / shares in Units, shares in Millions	3 Months Ended
	Apr. 30, 2024 USD ($) plan $ / shares shares	Apr. 30, 2023 USD ($) $ / shares shares	Sep. 30, 2023 USD ($)	Mar. 31, 2022 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock-based compensation plans | plan	3
Unrecognized compensation cost, options	$ 0
Employee stock purchase plan, compensation expense	$ 142,504,000	$ 144,706,000
Stock repurchase program, authorized amount				$ 200,000,000
Stock repurchase program, additional authorized amount			$ 300,000,000
Repurchases of common stock (in shares) | shares	2.5	0.7
Average price per share of stock repurchased (in usd per share) | $ / shares	$ 58.78	$ 57.06
Aggregate purchase price of stock repurchased	$ 149,063,000	$ 40,472,000
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, RSUs	$ 1,000,000,000
Unrecognized compensation cost, remaining weighted-average period for recognition	2 years 10 months 17 days
RSUs | Market Based and Performance Based Vesting Conditions
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date fair value of unvested RSU's	$ 116,600,000
Performance vesting percentage	100%
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee stock purchase plan, compensation expense	$ 3,000,000	$ 4,200,000
2018 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved for future issuance (in shares) | shares	47
2018 ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved for future issuance (in shares) | shares	12.1

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of RSU Activity (Details) - RSUs shares in Thousands	3 Months Ended
	Apr. 30, 2024 $ / shares shares
Number of Units
Unvested at beginning of period (in shares) | shares	26,700
Granted (in shares) | shares	1,192
Vested (in shares) | shares	(2,136)
Canceled (in shares) | shares	(1,469)
Unvested at end of period (in shares) | shares	24,287
Weighted-Average Grant Date Fair Value
Unvested at beginning of period (in usd per share) | $ / shares	$ 60.70
Granted (in usd per share) | $ / shares	54.47
Vested (in usd per share) | $ / shares	73.52
Canceled (in usd per share) | $ / shares	64.35
Unvested at end of period (in usd per share) | $ / shares	$ 58.79

Stockholders' Equity - Schedu_2

Stockholders' Equity - Schedule of Options Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2024	Jan. 31, 2024
Number of Options
Beginning balance (in shares)	1,385
Exercised (in shares)	(56)
Ending balance (in shares)	1,329	1,385
Weighted-Average Exercise Price Per Share
Beginning balance (in usd per share)	$ 17.39
Exercised (in usd per share)	11.43
Ending balance (in usd per share)	$ 17.64	$ 17.39
Weighted-Average Remaining Contractual Term (Years)
Outstanding balance	2 years 5 months 23 days	2 years 7 months 17 days
Aggregate Intrinsic Value
Outstanding balance	$ 51,643	$ 60,117

Restructuring and Other Relat_3

Restructuring and Other Related Charges - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring and other related charges	$ 29,124	$ 28,772
Stock-based compensation expense	142,504	144,706
Employee termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring and other related charges	29,100	27,700
Stock-based compensation expense	$ 4,600	$ 5,000

Restructuring and Other Relat_4

Restructuring and Other Related Charges - Schedule of Restructuring Liabilities (Details) $ in Thousands	3 Months Ended
	Apr. 30, 2024 USD ($)
2024 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring, beginning balance	$ 122
Accruals	0
Cash Payments	(122)
Restructuring, ending balance	0
2025 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring, beginning balance	0
Accruals	24,413
Cash Payments	(22,255)
Restructuring, ending balance	2,158
Other | 2024 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring, beginning balance	122
Accruals	0
Cash Payments	(122)
Restructuring, ending balance	0
Employee termination benefits | 2025 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring, beginning balance	0
Accruals	24,413
Cash Payments	(22,255)
Restructuring, ending balance	$ 2,158

Net Income per Share Attribut_3

Net Income per Share Attributable to Common Stockholders - Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Share Attributable to Common Stockholders (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Numerator:
Net income (loss) attributable to common stockholders, basic	$ 33,760	$ 539
Add: Interest expense on convertible senior notes	0	357
Net income attributable to common stockholders, diluted	$ 33,760	$ 896
Denominator:
Weighted-average common shares outstanding, basic (in shares)	205,870	202,631
Effect of dilutive securities (in shares)	4,026	5,440
Weighted-average common shares outstanding, diluted (in shares)	209,896	208,071
Net income per share attributable to common stockholders:
Basic (in usd per share)	$ 0.16	$ 0
Diluted (in usd per share)	$ 0.16	$ 0

Net Income per Share Attribut_4

Net Income per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities (Details) - shares shares in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	4,594	7,226
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	4,480	7,191
ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	114	35

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2025
Income Tax Contingency [Line Items]
Provision for income taxes	$ 2,833	$ 5,089
Unrecognized tax benefits	62,700
Unrecognized tax benefits that would impact effective tax rate	$ 10,800
Minimum | Forecast
Income Tax Contingency [Line Items]
Income tax expense impact related to valuation allowance release			$ 750,000
Maximum | Forecast
Income Tax Contingency [Line Items]
Income tax expense impact related to valuation allowance release			$ 850,000

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	May 05, 2024	May 31, 2024	Sep. 30, 2023
Subsequent Event [Line Items]
Stock repurchase program, additional authorized amount			$ 300,000,000
Subsequent Event
Subsequent Event [Line Items]
Stock repurchase program, additional authorized amount		$ 1,000,000,000
Subsequent Event | Lexion
Subsequent Event [Line Items]
Consideration to acquire outstanding stock	$ 165,000,000